Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan.
Takada N, Abe T, Shinohara N, Sazawa A, Maruyama S, Shinno Y, Sato S, Mitsuhashi K, Sato T, Sugishita K, Kamota S, Yamashita T, Ishizaki J, Hioka T, Mouri G, Ono T, Miyajima N, Sakuta T, Mochizuki T, Aoyagi T, Katano H, Akino T, Hirakawa K, Minami K, Kumagai A, Seki T, Togashi M, Nonomura K. Takada N, et al. Among authors: mochizuki t. BJU Int. 2012 Dec;110(11 Pt B):E756-64. doi: 10.1111/j.1464-410X.2012.11609.x. Epub 2012 Oct 29. BJU Int. 2012. PMID: 23107013
Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan.
Abe T, Ishizaki J, Kikuchi H, Minami K, Matsumoto R, Harabayashi T, Sazawa A, Mochizuki T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N. Abe T, et al. Among authors: mochizuki t. Urol Oncol. 2017 Feb;35(2):38.e1-38.e8. doi: 10.1016/j.urolonc.2016.08.016. Epub 2016 Sep 29. Urol Oncol. 2017. PMID: 27693091 Free article.
Outcome and prognostic factors in metastatic urothelial carcinoma patients receiving second-line chemotherapy: an analysis of real-world clinical practice data in Japan.
Matsumoto R, Abe T, Ishizaki J, Kikuchi H, Harabayashi T, Minami K, Sazawa A, Mochizuki T, Akino T, Murakumo M, Osawa T, Maruyama S, Murai S, Shinohara N. Matsumoto R, et al. Among authors: mochizuki t. Jpn J Clin Oncol. 2018 Aug 1;48(8):771-776. doi: 10.1093/jjco/hyy094. Jpn J Clin Oncol. 2018. PMID: 29939285 Free PMC article.
Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma.
Abe T, Minami K, Harabayashi T, Sazawa A, Chiba H, Kikuchi H, Miyata H, Matsumoto R, Osawa T, Maruyama S, Ishizaki J, Mochizuki T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Murai S, Shinohara N. Abe T, et al. Among authors: mochizuki t. Jpn J Clin Oncol. 2019 Oct 1;49(10):965-971. doi: 10.1093/jjco/hyz084. Jpn J Clin Oncol. 2019. PMID: 31187865 Free PMC article.
Erratum to: Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma.
Abe T, Minami K, Harabayashi T, Sazawa A, Chiba H, Kikuchi H, Miyata H, Matsumoto R, Osawa T, Maruyama S, IshizakiIshizaki J, Mochizuki T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Murai S, Shinohara N. Abe T, et al. Among authors: mochizuki t. Jpn J Clin Oncol. 2020 Jun 10;50(6):726. doi: 10.1093/jjco/hyz196. Jpn J Clin Oncol. 2020. PMID: 32382760 Free PMC article. No abstract available.
Oncological outcomes of a multicenter cohort treated with axitinib for metastatic renal cell carcinoma.
Osawa T, Kojima T, Hara T, Sugimoto M, Eto M, Takeuchi A, Minami K, Nakai Y, Ueda K, Ozawa M, Uemura M, Miyauchi Y, Ohba K, Suzuki T, Anai S, Shindo T, Kusakabe N, Tamura K, Komiyama M, Goto T, Yokomizo A, Kohei N, Kashiwagi A, Murakami M, Sazuka T, Yasumoto H, Iwamoto H, Mitsuzuka K, Morooka D, Shimazui T, Yamamoto Y, Ikeshiro S, Nakagomi H, Morita K, Tomida R, Mochizuki T, Inoue T, Kitamura H, Yamada S, Ito YM, Murai S, Nishiyama H, Shinohara N; Japanese Urological Oncology Group. Osawa T, et al. Among authors: mochizuki t. Cancer Sci. 2020 Jul;111(7):2460-2471. doi: 10.1111/cas.14449. Epub 2020 Jun 12. Cancer Sci. 2020. PMID: 32402135 Free PMC article.
Efficacy of nivolumab plus ipilimumab as first-line therapy for primary tumors in patients with renal cell carcinoma.
Kikuchi H, Osawa T, Matsumoto R, Abe T, Maruyama S, Harabayashi T, Miyata H, Kashiwagi A, Ikeshiro S, Sazawa A, Fukui R, Morita K, Takeuchi I, Hori K, Yamashita N, Minami K, Mochizuki T, Murai S, Shinohara N. Kikuchi H, et al. Among authors: mochizuki t. Urol Oncol. 2022 Jan;40(1):13.e19-13.e27. doi: 10.1016/j.urolonc.2021.09.014. Epub 2021 Oct 27. Urol Oncol. 2022. PMID: 34716079 Free article.
Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities.
Yamada S, Abe T, Sazawa A, Katano H, Suzuki H, Takeuchi I, Ishizaki J, Minami K, Morita K, Tsuchiya K, Takada N, Maru S, Ishikawa S, Sato S, Kawazu T, Yamashita T, Ono T, Mochizuki T, Akino T, Sasaki Y, Shinno Y, Furumido J, Miyata H, Kikuchi H, Matsumoto R, Osawa T, Shinohara N. Yamada S, et al. Among authors: mochizuki t. Urol Oncol. 2022 Jan;40(1):11.e17-11.e25. doi: 10.1016/j.urolonc.2021.09.005. Epub 2021 Oct 27. Urol Oncol. 2022. PMID: 34716081 Free article.
Effect of Simulation-based Training on Surgical Proficiency and Patient Outcomes: A Randomised Controlled Clinical and Educational Trial.
Aydın A, Ahmed K, Abe T, Raison N, Van Hemelrijck M, Garmo H, Ahmed HU, Mukhtar F, Al-Jabir A, Brunckhorst O, Shinohara N, Zhu W, Zeng G, Sfakianos JP, Gupta M, Tewari A, Gözen AS, Rassweiler J, Skolarikos A, Kunit T, Knoll T, Moltzahn F, Thalmann GN, Lantz Powers AG, Chew BH, Sarica K, Shamim Khan M, Dasgupta P; SIMULATE Trial Group. Aydın A, et al. Eur Urol. 2022 Apr;81(4):385-393. doi: 10.1016/j.eururo.2021.10.030. Epub 2021 Nov 14. Eur Urol. 2022. PMID: 34789393 Clinical Trial.
1,738 results